On the subject of predictive models to evaluate the diagnostic power of the APC promoter in bladder carcinogenesis, the ROC curve analysis demonstrated that our model has great ability to distinguish between BLCA patients from healthy controls which indicates that the methylation status of APC promoter serves as a promising biomarker for BLCA with an AUC of 0.76. Here, APC is linked to bladder transitional cell carcinoma.